Name: AmerisourceBergen Corp. (NYSE:ABC) | Analysis of Revenues
Creator: Stock Analysis on Net

Analysis of Revenues

Revenues as Reported

Revenues as Reported

AmerisourceBergen Corp., income statement, revenues

US$ in thousands

12 months ended:	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017
Human Health	207,284,444)	197,777,128)	182,171,487)	—)	—)	—)
Animal Health	4,815,758)	4,684,417)	4,216,462)	—)	—)	—)
U.S. Healthcare Solutions	212,100,202)	202,461,545)	186,387,949)	—)	—)	—)
Alliance Healthcare	21,890,402)	7,373,365)	—)	—)	—)	—)
Other Healthcare Solutions	4,601,271)	4,156,264)	3,508,106)	—)	—)	—)
International Healthcare Solutions	26,491,673)	11,529,629)	3,508,106)	—)	—)	—)
Intersegment eliminations	(4,869)	(2,331)	(2,129)	—)	—)	—)
Revenue	238,587,006)	213,988,843)	189,893,926)	—)	—)	—)

Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).

Revenue Trend Analysis: The overall revenue demonstrates a consistent upward trend from fiscal year ending September 30, 2019, through 2022. Revenue grew from approximately 189.9 billion US dollars in 2019 to 238.6 billion US dollars in 2022, reflecting significant growth over this three-year period.
Human Health Revenues: Revenues attributed to Human Health increased steadily each year from 182.2 billion US dollars in 2019 to 207.3 billion US dollars in 2022, representing a steady expansion of this segment.
Animal Health Revenues: This segment also showed growth, albeit at a slower pace in comparison to Human Health, rising from approximately 4.2 billion US dollars in 2019 to 4.8 billion US dollars in 2022. The growth appears stable and consistent over the observed years.
U.S. Healthcare Solutions Segment: The U.S. Healthcare Solutions category follows a similar positive trajectory as Human Health, with revenues increasing from roughly 186.4 billion US dollars in 2019 to 212.1 billion US dollars in 2022. The increase aligns closely with the overall growth patterns in Human Health.
Alliance Healthcare Revenues: Revenues for Alliance Healthcare appear only in 2020 and onwards, showing a notable jump from approximately 7.4 billion US dollars in 2020 to 21.9 billion US dollars in 2022, indicating rapid growth or possibly expanded operations or acquisitions influencing this segment during this period.
Other Healthcare Solutions: This segment shows consistent upward movement from about 3.5 billion US dollars in 2019 to 4.6 billion US dollars in 2022, reflecting modest but steady growth.
International Healthcare Solutions: With data starting in 2019, this segment exhibits accelerated growth, increasing from 3.5 billion US dollars in 2019 to 26.5 billion US dollars in 2022. This significant increase suggests a strong international expansion or diversification strategy within the healthcare solutions domain.
Intersegment Eliminations: Intersegment eliminations remain relatively small in absolute terms but show an increasing negative value from -2.1 million US dollars in 2019 to -4.9 million US dollars in 2022, possibly reflecting increasing internal transactions that require adjustment in consolidated figures.

Download chart